semaglutide gpl1 Another Weight-Loss Trial Win for Weekly GLP-1 Drug Decoding GLP-1 Weight Loss Medications
Description
Most patients notice appetite suppression within the first few weeks of treatment
October 13, 2017
Semaglutide and tirzepatide amplify fullness by slowing gastric emptying
Current evidence suggests there may be a link between GLP-1 medications and hair loss, particularly with semaglutide (Wegovy) and tirzepatide (Mounjaro), but researchers have not proven that the medication itself directly causes hair loss
Primary endpoints Energy expenditure and RER under indirect calorimetry, fat mass and adipocyte size, liver triglyceride content and histology, plasma lipids, and muscle performance form a coherent endpoint suite tied to ERR biology
